In hypoxia conditions, this system inhibited the expression of Bcl-2 and β-catenin by 51% and 56%, respectively, and increased the rates of apoptosis by 40% in HT29 CRC cells. This evidence concerns the gene BCL2 and colorectal carcinoma.